Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity

Documenti analoghi

• Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity
  di: Corrales, Leticia, et al.
  Pubblicazione: (2015)
• TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors
  di: Francica, Brian J., et al.
  Pubblicazione: (2018)
• Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
  di: Leong, Meredith, et al.
  Pubblicazione: (2013)
• Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants
  di: Dubensky, Thomas W., et al.
  Pubblicazione: (2013)
• The host STING pathway at the interface of cancer and immunity
  di: Corrales, Leticia, et al.
  Pubblicazione: (2016)